← Back to Clinical Trials
Recruiting NCT07235722

NCT07235722 How a Resilience-Focused Intervention is Perceived by Women Subjected to Domestic Violence

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07235722
Status Recruiting
Phase —
Sponsor Uppsala University
Condition Shame
Study Type OBSERVATIONAL
Enrollment 30 participants
Start Date 2026-04-07
Primary Completion 2026-11-01

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Qualitative interview

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 30 participants in total. It began in 2026-04-07 with a primary completion date of 2026-11-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

At Uppsala University Hospital, there is an outpatient clinic for women subjected to intimate partner violence. In order to explore how patients experience the biopsychosocial resilience-based intervention in use at the clinic and how well the intervention fits the needs of the patients, 30 patients from different stages of their contact at the clinic and with diverse life situations and background are enrolled. The researchers will carry out individual in-person interviews, each lasting approximately 60 minutes, based on a semi-structured set of questions. The questions concern the participant´s life situation, resilience and self-perceived needs, how well the intervention has met those needs and how it was perceived by the participant. The interviews are audio-recorded and transcribed verbatim for thematic analysis.

Eligibility Criteria

Inclusion Criteria: * Enrolled in the EMBER intervention at the NCK outpatient clinic. Exclusion Criteria: * Any situation that, in the opinion of the Investigator, would compromise the safety of the patient or the quality of the data.

Contact & Investigator

Central Contact

Tove Filén, PhD-student

✉ tove.filen@nck.uu.se

📞 +46721476848

Principal Investigator

Carolina Överlien, professor

PRINCIPAL INVESTIGATOR

The National Centre for Knowledge on Men's Violence Against Women, Uppsala university

Frequently Asked Questions

Who can join the NCT07235722 clinical trial?

This trial is open to female participants only, aged 18 Years or older, studying Shame. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07235722 currently recruiting?

Yes, NCT07235722 is actively recruiting participants. Contact the research team at tove.filen@nck.uu.se for enrollment information.

Where is the NCT07235722 trial being conducted?

This trial is being conducted at Uppsala, Sweden.

Who is sponsoring the NCT07235722 clinical trial?

NCT07235722 is sponsored by Uppsala University. The principal investigator is Carolina Överlien, professor at The National Centre for Knowledge on Men's Violence Against Women, Uppsala university. The trial plans to enroll 30 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology